S
Samjin Pharmaceutical Co Ltd
KRX:005500
Samjin Pharmaceutical Co Ltd
KRX:005500
Price:
19 140 KRW
-0.31%
Market Closed
Updated:
Jun 1, 2024
Samjin Pharmaceutical Co Ltd
Net Income (Common)
|
Samjin Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Comparables:
000100
326030
128940
S
000250
C
068760
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
Net Income (Common)
₩14.4B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
6%
|
|
|
Yuhan Corp
KRX:000100
|
Net Income (Common)
₩124.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
4%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Net Income (Common)
-₩32.9B
|
CAGR 3-Years
49%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Net Income (Common)
₩146.2B
|
CAGR 3-Years
130%
|
CAGR 5-Years
42%
|
CAGR 10-Years
13%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Net Income (Common)
-₩9.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Net Income (Common)
₩16.5B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
See Also
What is Samjin Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
14.4B
KRW
14.4B
KRW
Based on the financial report for Mar 31, 2024, Samjin Pharmaceutical Co Ltd's Net Income (Common) amounts to 14.4B KRW.
What is Samjin Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%
6%
Over the last year, the Net Income (Common) growth was -44%. The average annual Net Income (Common) growth rates for Samjin Pharmaceutical Co Ltd have been -18% over the past three years , -11% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
